Monday - April 20, 2026

Unity Biotechnology, Buck Institute for Research on Aging, Mayo Foundation for Medical Education

2018-05-31

ALEXANDRIA, Va., May 31 -- Unity Biotechnology, Brisbane, California, Buck Institute for Research on Aging, Novato, California, Mayo Foundation for Medical Education and Research, Rochester, Minnesota have been assigned a patent (No. 9,980,962, initially filed July 12, 2017) developed by nine co-inventors for the "use of sulfonamide inhibitors of Bcl-2 to treat senescence-associated lung conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease." The co-inventors are Remi-M . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Unity Biotechnology, Buck Institute for Research on Aging, Mayo Foundation for Medical Education

Information Request Form

Copyright Targeted News Service 2018